REGN vs SDOT · P/E 14, rev $14.34B vs rev $700.9M
Regeneron Pharmaceuticals Inc (REGN) versus Sadot Group Inc. (SDOT) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Sadot Group Inc. (SDOT) is a farm products company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported SDOT revenue for 2024-12-31 was $700.9M. Net income was $3.7M. Revenue was down 2.3% from 2023-12-31 to 2024-12-31. SDOT currently screens at market cap $17.4M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. SDOT currently screens at market cap $17.4M.
Not investment advice. Open the REGN and SDOT stock pages for the full models.
Not investment advice.